# Research on the Individualized Treatment Strategy for Extremely Preterm Infants With hsPDA Based on Biomarkers and Targeted Delivery Systems

> **NCT07374146** · — · NOT_YET_RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Hemodynamically Significant Patent Ductus Arteriosus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07374146
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07374146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07374146, "Research on the Individualized Treatment Strategy for Extremely Preterm Infants With hsPDA Based on Biomarkers and Targeted Delivery Systems". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07374146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*